Gene deletion of neurotrophin-3 (NT3) results in severe sensory and sympathetic deficits that are incompatible with postnatal life in mice. We have now addressed the question of whether NT3 plays a role in the postnatal animal. An antiserum specific for NT3 and capable of blocking the survival effect of the factor in vitro has been generated and given to neonatal rats. Antiserum administration during either or both of the first 2 postnatal weeks resulted in a 54-74% reduction in the size of the superior cervical ganglia, reflecting a loss of as many as 80% of all neurons, with a predominant effect on the neuropeptide Y containing subpopulation.
The immunoreactivities of NPY, tyrosine hydroxylase, and p75 low affinity NGF receptor in nerve terminals within the mesenteric artery were also reduced, whereas that of the sensory neuron neuropeptide, calcitonin gene related peptide was less affected. These results demonstrate that the majority of sympathetic neurons of the neonatal rat are dependent on endogenous NT3 for their survival at a time when they are also dependent on another survival factor, NGF, thus apparently providing a clear example of a population of neurons requiring for their survival the simultaneous supply of more than one trophic factor.
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The neurotrophins are a family of target-derived neurotrophic factors consisting of four structurally related proteins including NGE brain-derived neurotrophic factor (BDNE Barde et al., 1982; Leibrock et al., 1989) neurotrophin-3 (NT3; Ernfors et al., 1990; Hohn et al., 1990; Maisonpierre et al., 1990; Rosenthal et al., 1990) , NT4/5 (Berkemeier et al., 1991; Hallbook et al., 1991; Ip et al., 1992) , and NT6 (Giitz et al., 1994) . They each support the survival of distinct, but overlapping neuronal populations in vitro. Depriving animals of neurotrophins or their receptors either by administration of specific antibodies or gene deletion results in a variety of neuropathies (Johnson et al., 1980; Ruit et al., 1991 Ruit et al., , 1992 Klein et al., 1993 Klein et al., , 1994 Crowley et al., Received Feb. 3, 1995; revised May 15, 1995; accepted June 5, 1995. We thank Ron Lindsay of Regeneron for rhBDNF, rhNT3, and rhNT4 used for the production and characterization of NT3 antiserum, Eugene et al., 1994a,b; Farinas et al., 1994; . In a recent study, antibody to NT3 has been given to developing chickens, demonstrating a role for NT3 in survival and maturation of sensory neurons as well as glia (Barres et al., 1994; Gaese et al., 1994) . Neurotrophins bind to both low and high affinity receptors on target cells to elicit a cascade of intracellular responses to produce their biological effects (for review, see Chao, 1992; Raffioni et al., 1993) . The low affinity neurotrophin receptor (p75NGFR) is a 75 kDa glycoprotein that binds all four neurotrophins with similar characteristics and is highly expressed in both neuronal and non-neuronal tissue during development and in the adult (Chao et al., 1986; Yan et al., 1988 Yan et al., , 1989 . Three high affinity neurotrophin receptors named trkA, trkB, and trkC have been identified in the last few years (Martin-Zanca et al., 1989; Klein et al., 1991a; Lamballle et al., 1991 ; for review, see Barbacid, 1993) and are expressed in both the PNS and CNS (Klein et al., 1990; Martin-Zanca et al., 1990; Tessarollo et al., 1993; Zhou et al., 1993b; Lamballe et al., 1994) . In general, it is agreed that trkA functions as a high affinity receptor for NGF Klein et al., 1991b) , trkB for BDNF and NT4 (Klein et al., 1991b (Klein et al., , 1992 Soppet et al., 1991; Squint0 et al., 1991) , and trkC for NT3 . This specificity is not absolute as some cross-talk is apparent (Ip et al., 1993; for review, see Barbacid 1993) .
The genesis, development and cell death phases of sympathetic neurons have been well described (De Champlain et al., 1970; Aauaya et al., 1973 Aauaya et al., , 1976 Hendry, 1977; Wright et al., 1983 , Rubin, 1985a . Sympathetic precursor cells in the rat first appear on El 1 in the thoracic region or on El2 in the cervical region. These cells proliferate, migrate and aggregate forming ganglia along the sympathetic chain between El2 and El4 (Rubin, 1985~) . Differentiation begins on El2 and the first axons emerge a few days later. Maturation continues with the synthesis of catecholamines, preganglionic inputs and dendrite formation (Rubin, 1985a-c) . The number of differentiated neurons reaches a peak by birth. Postnatally, a proportion of neurons die after their axons arrive into peripheral innervation fields. Approximately one-third of all neurons in the superior cervical ganglion (SCG) die during the first week after birth when these neurons critically rely on NGF for their survival (Wright et al., 1983) . This naturally occurring sympathetic neuron death can be prevented by exogeneous NGF (Hendry and Campbell, 1976) or exaggerated by depletion of endogenous NGF with antibodies (Levi-Montalcini and Booker, 1960; Hendry and Campbell, 1976; Goedert et al., 1978) .
These experiments, demonstrating the physiological role of NGF in sympathetic neurons, have established the fundamental theory of neurotrophism. However, indirect evidence has shown that subpoulations of sympathetic neurons are also dependent on factors other than NGE For example, during late development sympathetic neurons express both trkA and trkC (Dixon et al., 1994) , suggesting both NGF and NT3 are required. NT3 is known to bind specifically to sympathetic neurons (Dechant et al., 1993) and to support the survival of sympathetic neurons of the chick embryo and mouse neonate in vitro (Maisonpeirre et al., 1990; Rosenthal et al., 1990; Lee et al., 1994) . NT3 is also shown to increase the number of mature sympathetic neurons by promoting the survival of proliferating sympathoblasts (Birren et al., 1993; DiCicco-Bloom et al., 1993) . Furthermore, consistent with these in vitro studies, deletion of the NT3 gene results in severe sympathectomy in neonatal mice (Ernfors et al., 1994b; Farinas et al., 1994) . However, the question of whether NT3 acts as a survival factor postnatally in the intact animal has not been addressed. To answer this question, we have raised polyclonal NT3 antibodies in rabbits which specifically block the biological activity of NT3 both in vitro and in vivo. The NT3 neurotrophic action has been dissociated from its mitogenic or proliferative action by administration of the antiserum to neonatal rats. Our study shows that NT3 is a survival factor for postnatal sympathetic neurons at a time when they are also dependent on NGE
Materials and Methods

NT3 antiserum
The antiserum was raised against rhNT3 in a rabbit according to a method developed for small molecules (Pow and Crook, 1993) . Briefly, 50 kg of rhNT3 was conjugated to porcine thyroglobulin with glutaradehyde and injected into a rabbit as described previously (Zhou et al., 1993a) . The antiserum used for this study was collected after 12 injections.
Dot blot
Different amounts of mouse NGF, rhBDNF, and rhNT3 in 1 ~1 of PBS were dotted on nitrocellulose paper as shown in Figure 1 .1. After blocking in 20% normal horse serum (NHS), the membrane was incubated overnight in the NT3 antiserum at a dilution of 1 in 2000 in PBS containing 1% NHS and 0.3% Triton X-100. The membrane was rinsed, washed three times (15 min each) in PBS containing 1% Tween-20 (PBST), and incubated in biotinylated antibodies to rabbit IgG (1:500 dilution; Vector Lab) in PBS containing 1% NHS for 2 hr at room temperature. After several washes the membrane was incubated in ABC complex (1:lOO dilution; Vector Lab) for 1 hr at room temperature. After rinsing in Tris buffered saline (TBS) the membrane was developed in TBS containing 0.05% diaminobenzidine (DAB), 0.3% nickel sulfate and 0.002% H,O, for 10 min at room temperature.
Bioassay
Fertile White Leghorn eggs were incubated at 38°C in a moisturized incubator. Chick dorsal root ganglia (DRG) were dissected at E8 and cultured in RPM1 1640 cult&e iedi;m from CSL supplemented with 10% fetal calf serum containing 10 rig/ml of mouse NGF, rhBDNE or rhNT3 in the presence or absence of antiserum to rhNT3 at the dilutions shown in Figure 1 .2. After 24 hr culture, the neurite outgrowth from each ganglion was scored according to Ebendal et al. (1980) . Each point represents an average of 3-5 DRG results.
Treatment of neonates with NT3 antiserum
Three experiments were performed with two groups of rats in each experiment. Experiment 1: Rats were injected subcutaneously (s.c.) with either NT3 antiserum or normal rabbit serum (NRS; n = 5 for each group) on postnatal days (P) 1 (10 $/gm body weight; b.w.), 3, 5, and 7 (5 pJ/gm b.w. for other time points). Treated and control rats were killed at P8 by anaesthetic overdose and perfused with 0.1 M phosphate buffer followed by Zamboni's fixative. Experiment 2: Rats were injected S.C. with either the NT3 antiserum or NRS (n = 4 for each group) every second day from Pl (10 pg/gm b.w.) to P13 (5 FVgm b.w. for other time points). The rats were killed at P14 as described above. Experiment 3: Rats were injected S.C. with either NT3 antiserum or NRS (n = 4 for each group) at P7 (10 Qgm b.w.), P9, Pll, and P13 (5 @/gm b.w. for other time points) and killed at P14 as described above. SCG, stellate ganglia (SG), superior mesenteric ganglia (SMG), L, DRG and trigeminal ganglia were dissected and ganglia weighed and photographed after removal of moisture and surrounding tissues.
Histology SCG were dehydrated in graded alcohols and xylene, embedded in paraffin and sectioned at 10 pm. Sections were dewaxed in xylene, rehydrated in graded alcohol and water, stained with 1% thionin and observed under a light microscope. Neurons with visible nuclei and wellstained cytoplasm were counted with a 20X objective on every fifth section. The diameters of more than 100 nuclei in the largest section were measured with a 40X objective. The total number of neurons was calculated and corrected with Abercrombie's equation (Abercrombie et al., 1946) . The significant differences between control and experimental groups were tested with an unpaired Student's r test.
Measurement of soma area of sympathetic neurons
Several sections of NRS-and NT3 antiserum-treated SCG from experiment 2 were used for the measurement of soma size of sympathetic neurons. Two diameters at right angles were measured at 400X magnification in each neuron having a clear nucleus. Soma areas were calculated with the formula dl Xd2 X~rl4 described previously (Zhou et al., 1994b) , where dl and d2 represent the two diameters. The size distribution of soma areas from each treatment was plotted as a percentage of the total numbers of neurons measured.
Immunohistochemistry NGF in SCG. Sprague-Dawley rats, 6 weeks of age, were injected intraperitoneally (i.p.) with either 1.5 ml of NRS, NGF antiserum or NT3 antiserum; 72 hr after injection, the rats were briefly perfused with 50 ml of acetate buffer, pH 3.0 (5% acetic acid), followed by 500 ml of Zamboni's fixative as previously described (Zhou et al., 1994a) . SCG were dissected, postfixed in Zamboni's fixative for 2 hr, cryoprotected in 30% sucrose for 1 hr and sectioned at 30 pm with a cryostat microtome. The free floating sections were washed three times (15 min each) in 50% ethanol and once in PBS, blocked in 20% NHS and incubated overnight in affnity purified NGF antibodies (1 pg/ml) raised in sheep. The sheep NGF antibodies have been characterized previously by immunoblot (Zhou et al., 1994a) and ELISA (Zettler et al., unpublished observations) , showing that they recognize NGF but not BDNF or NT3. After washing in PBST, the sections were incubated in biotinylated secondary antibodies against sheep IgG (1:500 dilution; Vector Lab) for 2 hr and followed by ABC kit (1:200 dilution) for 1 hr with washes between incubations. The sections were developed in DAB solution with nickel intensification. The sections were dehydrated in graded alcohols and xylene and mounted in xylene based medium for observation and photography.
NPY, p75NGFR, TH, and CGRP in SCG and mesenteric arteries.
Paraffin embedded SCG were sectioned at 10 pm and processed for immunohistochemistry for NPY, and p75NGFR and TH. Mesenteric arteries were dissected free from connective tissues and veins. Whole tissues were pinned on a petri dish and processed for NPY, TH, p75NGFR, and CGRP. NPY antiserum raised in sheep was diluted at 1:2000 (for SCG) or 1:5000 (mesenteric arteries), mouse monoclonal antibody to TH (INCSTAR, lot# 22941) was diluted at l:lOOO, mouse monoclonal LNGFR antibody (IgG192) was diluted at 1:500 and CGRP antibodies raised in goat was diluted at 1:5000. Sections and mesenteric arteries from control and experimental groups were mounted on the same slides or treated in the same petri dish, and processed and developed for the same length of time to reduce variability. After development, mesenteric arteries were mounted on gelatin-coated slides, coverslipped, observed, and photographed.
Results
Characteristics of the NT3 antiserum Dot blot analysis ( Fig. 1.1) showed that the NT3 antiserum has no crossreactivity with NGF even at an amount of 100 ng but slight (0.1%) cross-reactivity with rhBDNE The antiserum could detect as little as 0.1 ng of rhNT3. Bioassays ( Fig. 1.2) showed that mouse (m) NGE rhBDNE and rhNT3 all promoted DRG explant outgrowth and that NT3 antiserum at dilutions of 1: 100 to 1:30,000 could inhibit only the growth induced by NT3. These results indicate that the antiserum used in this study is specific for NT3 with little or no crossreactivities with BDNF or NGE This conclusion is further supported by additional experiments. Immunoassays showed that the NT3 antiserum crossreacted with mNGF at a level of approximately 0.2% (data not shown). Furthermore, our "in vivo adsorption" technique (Zhou et al., 1994a ) was used to show that NT3 antiserum did not deplete the endogenous NGF immunoreactivity accummulated in sympathetic neurons of SCG. Since in neonatal animals the administration of both NGF and NT3 antisera results in the death of sympathetic neurons, this experiment was performed in older rats. Figure 2 shows that, in 6 week old rats, NGF-ir is readily detectable in most sympathetic neurons after injection of NRS three days earlier (Fig. 2.1 ), but not in neurons from animals treated with NGF antiserum (Fig. 2.2) . In contrast, injection of NT3 antiserum had little effect on NGF-ir ( Fig. 2.3) , indicating the inability of this antiserum to block the uptake and transport of endogenous NGF by sympathetic neurons.
Effects of NT3 antiserum on sensory and motor neurons No significant differences were seen in animal sizes between NRS and NT3 antiserum treated pups. The feeding behaviour '. I s Figure   2 . Localization of NGF-like immunoreactivity in sympathetic neurons of SCG with NGF immunohistochemistry in 6 week old rats. 1, Normal rabbit serum treated SCG showing NGF-ir in sympathetic neurons. 2, NGF-ir in sympathetic neurons was absent in animals treated with NGF antiserum. 3, NGF-ir in sympathetic neurons was not significantly changed in animals receiving NT3 antiserum. Scale bar, 100 pm. and movement development of antiserum treated rats were also normal. The weights of L, DRG (0.85 -+ 0.05) and trigeminal ganglia (5.42 ? 0.26 mg) in antiserum treated pups were slightly, but significantly, reduced compared with controls (DRG: 1.15 2 0.04 mg, P < 0.01; trigeminal ganglia: 6.62 ? 0.27 mg, P < 0.01). No obvious morphological changes in sensory neurons of L5 DRG and motor neurons in brain stem and spinal cord were seen after antiserum treatment for 1 or 2 weeks. Effect of NT3 antiserum on sympathetic neurons Injection of NT3 antiserum to neonatal rats in all three experiments significantly reduced the volume of sympathetic ganglia including SCG, SG, and SMG. Administration of the antiserum for two weeks (from Pl to P14, experiment 2) induced the most significant damage, markedly reducing the size of the SCG, SG and SMG (Fig. 3) . Quantitative data showed that the weights of the SCG and SG in these rats were reduced by 74.3% and 73.4%, respectively, in comparison with normal rabbit serum (NRS) controls (Table 1) . Interestingly, the use of the antiserum for one week either from Pl to P8 (experiment 1) or from P7 to P14 (experiment 3) resulted in a less marked, but still highly significant reduction of SCG weight.
The reduction of SCG size was accompanied by a significant loss of sympathetic neurons (Fig. 4, Table 2 ). As shown in Figure 4. 2, a few, widely dispersed neurons from experiment 2 can be seen scattered across the section surrounded by increased numbers of non-neuronal cells. Pyknotic cells in each section from antiserum treated rats could be easily identified and the number of non-neuronal cells was also increased. The total number of neurons in the SCG of NT3 antiserum-treated rats from experiment 2 was reduced by 80.6%. As shown in Figure 4 .3, neurons in the SCG from rats killed at P8 after NT3 antiserum treatment (exepriment 1) were smaller and contained less cytoplasm than controls. Their total number was reduced by 60.4%. In those animals treated with antiserum for the second postnatal week only (experiment 3), the density of sympathetic neurons was also significantly reduced (Fig. 4.4) with the total number of neurons decreased by 61.3%.
Effect of NT3 antiserum on the size distribution of soma areas In SCG from control in experiment 2, the size distribution of neuronal soma areas ranging from 74 to 460 pm2 with an av: erage of 2346 pm2 (Fig. 5) . In contrast, the average soma areas of neurons from antiserum-treated rats was 265 t 11 mm* with a much wider distribution range of 33-817 p,*. These differences were highly significant (p < 0.01) and indicated a shift away from the mean towards both extremities, suggesting that most sympathetic neurons undergo either atrophy and hypertrophy as a consequence of the antiserum treatment.
Effects of NT3 antiserum on neuronal markers Immunohistochemical data showed that the intensity of the tyrosine hydroxylase (TH) immunoreactvity (ir) in the remaining sympathetic neurons of the NT3 antiserum treated rats in experiment 2 was similar to NRS controls (data not shown). Neuropeptide Y (NPY)-ir neurons in P14 control SCG represented 58% of the total (Fig. 6.1 ) whereas only 28% of neurons were NPY-ir in NT3 antiserum treated rats (Fig. 6.2, Table 3 ). Compared with the NRS controls ( Fig. 6.3) , the number of NPY-ir nerve terminals innervating mesenteric arteries was also reduced after NT3 antiserum treatment (Fig. 6.4) . However, the staining intensity of the surviving NPY-ir terminals was not reduced. Figure 6 .5 and Figure 6 .7 show the localization of tyrosine hydroxylase (TH)-ir and p75NGFR-ir within the nerve terminals in NRS treated rats. Both the intensity and the number of THir as well as p75NGFR-ir nerve teminals of mesenteric arteries were significantly reduced after NT3 antiserum treatment (Fig. 6.6 and 6.8) . The number of calcitonin gene-related peptide (CGRP)-ir fibers also appeared to be slightly reduced in this tissue (Fig. 6 .9 and 6.10).
Discussion
Antiserum speci$city The specificity of the antiserum used in these experiments is critical to the validity of the findings. Therefore, several experiments were performed to demonstrate that the NT3 antiserum used is specific for this neurotrophin only and, in particular, has little or no cross-reactivity with NGE First, the NT3 antiserum reacted with rhNT3 in the range of 0.1-100 ng/pl but showed no cross-reactivity with mNGF on dot blot analysis even at the highest concentration (Fig. 4.1) . Cross-reactivity with rhBDNF was estimated at a maximum of 0.1%. Second, bioassays showed that mNGR rhBDNE and rhNT3 all promoted DRG explant outgrowth, but that only NT3-induced growth was inhibited by the NT3 antiserum. This effect was seen at antiserum dilutions ranging from 1:lOO to 1:30,000 (Fig. 4.2 ). Third and most importantly, "in vivo absorption" of NT3 with the specific antiserum in older rats failed to reduce the level of NGF-ir in . Histological analysis of thionin stained sections from superior cervical ganglia of control and treated rats. I, Micrograph from a section of the NRS treated rats of experiment 2; 2, section from NT3 antiserum treated rat of experiment 2; 3, section from NT3 antiserum treated rat of experiment 1; 4, section from NT3 antiserum treated rat of experiment 3. Scale bar, 100 km.
sympathetic neurons of SCG. In contrast, NGF-ir is lost from these neurons in rats injected with rabbit antiserum to NGF (Zhou et al., 1994a) . These experiments indicate that the NT3 antiserum is unable to significantly block the uptake of endogenous NGF into these neurons. Fourthly, the antiserum fails to detect NGF-ir within the mouse salivary gland under conditions which allow detection with NGF antiserum (data not shown).
Finally, the NT3 antiserum shows less than 0.2% cross-reactivity with NGF in a two site ELISA. These results indicate that the antiserum used in this article is specific to NT3, displaying little or no cross-reactivity with BDNF or NGF, so that the findings are unlikely to be due to an inhibition of endogenous NGE Al- -14) 21,545 '-llOO(4) 8300 + 400 (4) 61.3%** **. P < 0.001.
though there are reports that some antisera to neurotrophins show limited cross-reactivity with other members of the family (Murphy et al., 1993; Negro et al, 1993) , specific antisera have also been described (Ruit et al., 1991 (Ruit et al., , 1992 Zhou et al, 1994a; Zettler et al., unpublished observations) .
Effect of NT3 antiserum on neuronal markers
In the present study, we have found that the NT3 antiserum significantly reduced the immunoreactivities of neuronal markers NPY, TH, p75NGFR, and possibly CGRP in the mesenteric arteries.The extent of the loss of these neuronal markers varied, so that NPY-ir and TH-ir were most affected and CGRP-ir least affected. The reduction of these neuronal markers may simply reflect a reduction of sympathetic innervation within the artery as a result of the neuronal loss in sympathetic ganglia, or alternatively, a downregulation of these markers from a subpopulation of the neurons. Loss of CGRP-ir in the mesenteric arteries may reflect either its loss from sympathetic neurons expressing CGRP-ir (Schmitt et al., 1988; Kummer and Heym, 1991; Majewski and Heym, 1992; Heym et al., 1993) is indirect evidence showing that NPY-ir in sympathetic neurons is regulated by factors distinct from NGF (Cowen et al., 1993) . For example, injury to sensory innervation of tooth pulp induces sprouting of substance P (SP)-ir and CGRP-ir sensory, but not NPY-ir sympathetic fibers (Edwall et al., 1985; Oswald and Byers, 1993) . Also, no compensatory sprouting of NPY-ir sympathetic fibers was found after sensory denervation of tooth pulp in cats (Edwall et al., 1985) or rats (Oswald and Byers, 1993) . Furthermore, mRNANPY expression in the SCG of rat is not altered by NGF treatment (Miller et al., 1991) . However within the SMG, NPY-ir neurons appear sensitive to NGF antibodies, although a non-NGF sensitive population of neurons innervating the enteric plexuses has been demonstrated (Hill et al., 1985) .
Effect of NT3 antiserum on the size distribution of soma Hypertrophy of a subpopulation of sympathetic neurons following NGF antibody treatment in neonatal rats is a well-documented phenomenon (Cohen, 1960; Levi-Montalcini and Booker, 1960; Hendry and Campbell, 1976) . In the present study we found that NT3 antiserum treatment induced both hypertrophy and atrophy. The reason for the hypertrophy is not clear. Exogenous NGF applied to neonatal animals can induce the hypertrophy of sympathetic neurons (Hendry and Campbell, 1976) . It is therefore possible that more NGF in the targets is available for the few surviving sympathetic neurons. The atrophy of sympathetic neurons following the NT3 antiserum treatment may be due to the reduced trophic support resulting from the depletion of endogenous NT3.
NT3 is a survival factor for sympathetic neurons
The use of gene deletion experiments has provided important new information concerning the physiological roles of the neurotrophins (Crowley et al., 1994; Ernfors et al., 1994a,b; Farinas et al., 1994; Jones et al., 1994) . However, the usefulness of the technique is currently limited by the inability to time the onset of growth factor depletion; a limitation which we have sought to overcome by production of high titer, specific antisera to each factor. The current study has identified an ability of such an antiserum to kill the majority of sympathetic neurons in neonatal rats, thus indicating that endogenous NT3 acts as a survival factor for these neurons. The results are, of course, reminiscent of experiments performed by Cohen (1960) and Levi-Montalcini and Brook (1960) showing that the administration of NGF antiserum to neonatal animals leads to widespread sympathectomy. That one neuron is dependent in vivo on two separate factors raises the intriguing question of whether both neurotrophins are required for neuronal survival sequentially or in parallel. Since more than 80% reduction in neuron number is achieved by depletion of either NGF or NT3, there is little indication that each neurotrophin supports a separate neuronal population, with the possible exception of the SMG. While our findings indicate an overlapping dependence on two factors, there is also recent evidence for a sequential action. A switch in survival factor requirement in vitro from NT3 to NGF can be demonstrated during the late embryonic period and is accompanied by a change in synthesis of neurotrophin receptors from trk C to trk A (Schecterson and Bothwell, 1992; Birren et al., 1993; DiCiccoBloom et al., 1993) , although trk C expression continues for several weeks postnatally (Dixon et al., 1994) . Deletion of either the NGF (Crowley et al., 1994) or NT3 gene (Ernfors et al. 1994b; Farinas et al., 1994b) in embryonic mice results in more than 50% reduction of sympathetic neurons, but this finding does not rule out a parallel or overlapping action. Is the sensitivity to NT3 uncovered in the present experiments due to a declining sensitivity of immature neurons or are sympathetic neurons sensitive to the factor throughout the life of the animal? Evidence for the latter possibility is only indirect at present, but nevertheless should be considered. In adult rats, sympathetic neurons are capable of transporting labeled NT3 (DiStefano et al., 1992) and preliminary evidence indicates that trk C-ir is present within sympathetic nerve terminals of the mesenteric artery (Zhou, Vahaviolos, and Rush, unpublished findings) . In situ hybridization studies (Scarisbrick et al., 1993) and biochemical analysis (Zhou, Palm and Rush, unpublished data) have identified the presence of mRNANT3 in the wall of aorta of embryonic animals and in extracts of the mesenteric vasculature from 3 week old rats. Finally, post-mortem analysis indicates that the volume of sympathetic ganglia from one NT3 immunized rabbit (the antiserum from which was used in this study) were reduced in size compared with animals immunized with other molecules. Thus, there is sufficient indirect evidence to suggest that the requirement for NT3 may persist into adult life. Figure   6 . Effects of NT3 antiserum on immunoreactivities of NPY in SCG (panels I and 2) and NPY, TH, LNGFR, and CGRF' in mesenteric arteries (panels 3-10). Samples from three NT3 antiserum and three NRS treated-rats as described in experiment 2 were processed simultaneously for immunohistochemistry and yielded consistent results. Panels I, 3, 5, 7, and 9 are from NRS treated rats and 2, 4, 6, 8, and 10 from NT3 antiserum treated rats. Scale bar, 100 pm. The simplest explanation for our findings is that neonatal sympathetic neurons survive as a result of the supply of both NGF and NT3. How these two factors interact is not clear. It is possible that NT3 acts indirectly via the regulation of trkA expression in the sympathetic neurons. Recently, Verdi and Anderson (1994) showed that NT3 upregulates trkA expression in sympathetic neuroblasts and differentiated neurons in culture. Thus depletion of endogenous NT3 may result in a downregulation of trkA leading to a reduced supply of NGF to the neurons. The possibility that the sympathectomy seen in earlier experiments using NGF antisera was due to an effect by contamination NT3 antibodies seems unlikely, since we have previously used a rabbit NGF antiserum for such studies (Hill et al., 1988) and now shown that this antiserum shows no significant cross-reactivity with NT3 (Zhou et al 1993; 1994) .
There is evidence for distinct signaling pathways by the different trk C isoforms (Lamballe et al., 1993; Tsoulfas et al., 1993) , so that a simultaneous and totally independent requirement for both factors is possible. However, several other possibilities deserve further investigation. Estimation of NGF levels in the rat SCG has shown that its concentration is very low at birth and rises only slowly during the first 2 postnatal weeks (Korsching and Thoenen, 1988) . Even at 2 weeks of age the concentration is only about 30% of that within the adult. Thus NT3 levels within the ganglia may decline as the NGF levels increase. Loss of significant quantities of either NGF or NT3 might then be expected to result in cell death. Alternatively, NT3 may be provided from preganglionic fibers since preganglionic neurons are known to provide essential trophic support during development which cannot be explained totally by the action of ACh (for review, see Hendry, 1976; Black, 1978) . A possible indirect action of NT3 antiserum via downregulation of trk A receptors has been discussed above. Finally, if heterodimers of NGF and NT3 (Junbluth et al., 1994) exist in viva, such a molecule might be inhibited by NGF and NT3 antisera. Each of these possible mechanisms is currently under investigation.
